182 related articles for article (PubMed ID: 17877580)
1. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas.
Paciello O; Borzacchiello G; Varricchio E; Papparella S
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis.
Kang HJ; Cinn YG; Hwang SJ; Won Chae S; Woo JS; Lee SH; Lee HM
Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1196-200. PubMed ID: 17116814
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
4. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins expression in canine intracutaneous cornifying epithelioma and squamous cell carcinoma.
Romanucci M; Bongiovanni L; Marruchella G; Marà M; di Guardo G; Preziosi R; della Salda L
Vet Dermatol; 2005 Apr; 16(2):108-16. PubMed ID: 15842541
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
Borzacchiello G; Paciello O; Papparella S
J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
[TBL] [Abstract][Full Text] [Related]
7. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
8. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
12. Nasal and paranasal adenocarcinomas with neuroendocrine differentiation in dogs.
Ninomiya F; Suzuki S; Tanaka H; Hayashi S; Ozaki K; Narama I
Vet Pathol; 2008 Mar; 45(2):181-7. PubMed ID: 18424830
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.
Matthiessen MW; Pedersen G; Albrektsen T; Adamsen S; Fleckner J; Brynskov J
Scand J Gastroenterol; 2005 Feb; 40(2):198-205. PubMed ID: 15764152
[TBL] [Abstract][Full Text] [Related]
14. Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injury.
Yoshimura R; Matsuyama M; Segawa Y; Tsuchida K; Takemoto Y; Kuratsukuri K; Kawahito Y; Shinka T; Sano H; Nakatani T
Transplant Proc; 2004 Sep; 36(7):1946-8. PubMed ID: 15518707
[TBL] [Abstract][Full Text] [Related]
15. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.
Herrera CL; Kim DY; Kumar SR; Bryan JN
BMC Vet Res; 2015 Sep; 11():230. PubMed ID: 26334880
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
Duan SZ; Usher MG; Mortensen RM
Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
[TBL] [Abstract][Full Text] [Related]
19. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
He Q; Chen J; Lin HL; Hu PJ; Chen MH
Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma in malignant diseases.
Wang T; Xu J; Yu X; Yang R; Han ZC
Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
